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Visualizing Myocardial Salvage: New Methods,
New Insights*
Nathaniel Reichek, MD,†‡ Visali Kodali, MBBS‡
Stony Brook and Roslyn, New YorkSince the earliest days of the thrombolytic era,
maximizing myocardial salvage by reperfusion of
the myocardial region at risk for myocardial infarc-
tion has been the most important immediate objec-
tive in management of ST-segment elevation myo-
cardial infarction (STEMI) (1). The roles of time to
reperfusion and collateral flow to the infarct terri-
tory and their impact on early and late post-infarct
ventricular function were recognized in those early
See page 491
days. However, tools for quantitation of myocardial
salvage have been scarce and difficult to use. A few
studies have been done with radionuclide imaging,
using immediate injection of sestimibi before reper-
fusion to depict the risk region, with scanning after
reperfusion, combined with a later reinjection and
scan post-reperfusion to depict the reperfused viable
myocardium (2–4). The difference in size between
the initial perfusion defect and the post-reperfusion
perfusion defect then represents myocardial salvage,
whereas the perfusion defect on the post-
reperfusion scan represents infarct size. However,
this approach has been difficult to implement on a
large scale. In this issue of iJACC, a potentially
important study by Ortiz-Pérez et al. (5) applies a
recently developed approach using the BARI (By-
pass Angioplasty Revascularization Investigation
Myocardial Jeopardy Index) score (6) for estimation
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Foundation.of the size of the myocardial risk region, expressed
as percent left ventricular myocardium, while using
cardiac magnetic resonance (CMR) delayed en-
hancement imaging to quantitate infarct size (7–9).
A myocardial salvage index (MSI) is then calculated
as the ratio of myocardial salvage to total LV wall
volume (MSI  [myocardial salvage/total left ven-
tricular wall volume]  100). Use of the BARI
score to determine the size of the risk region has
been previously validated by this group in an
analysis of results in 83 patients undergoing
percutaneous coronary intervention (PCI) for
STEMI with a completely occluded culprit vessel
(Thrombolysis In Myocardial Infarction [TIMI]
flow grade 0) (10). In that study, there were 35
subjects with transmural infarction by CMR, in
whom the risk region was presumably completely
infarcted. In those subjects, there was an excellent
correlation between BARI score–predicted risk
region size and infarct size. In addition, the
endocardial surface area of the infarct by CMR in
all subjects with time to reperfusion over 1 h
correlated well with the BARI score risk region
size, independent of collateral flow or time to
reperfusion. Both early reperfusion and the pres-
ence of visible collateral were associated with
reduced infarct transmurality and trends to
smaller infarct size. Other investigators have
found less agreement between BARI score and
endocardial infarct surface area, but this is likely
due to inclusion of patients with substantial
antegrade flow in the infarct vessel in their
analysis (11).
In the present study, the authors have apparently
added to the previously evaluated cohort an addi-
tional 38 patients with residual antegrade flow in
the culprit vessel, TIMI flow grade 1 to 3 at the
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502ocus purely on determinants of salvage, not valida-
ion of the methods. They have assessed the impact
f pre-reperfusion antegrade flow, collateral flow,
ime to reperfusion, and CMR microvascular ob-
truction on the MSI and have also examined the
elationship of these variables to wall motion score,
o major adverse cardiac events (MACE) (cardiac
eath, admission for heart failure, or need for heart
ransplantation), and to changes in wall motion
core at follow-up.
The results demonstrate that, in contrast to
atients with TIMI antegrade flow 0 to 1, initial
IMI flow grade 2 to 3 was associated with smaller
nfarcts, more myocardial salvage, and less infarct
ransmurality, as well as lower wall motion scores
nd fewer MACE events. In patients with initial
IMI flow grade 0 to 1, those with good collat-
rals (grade 2) also had higher ejection fraction,
etter wall motion score, less infarct transmural-
ty, and a trend toward higher MSI than those
ith poor collaterals (grade 1, n  65). As
xpected, increasing time to reperfusion was as-
ociated with reduced myocardial salvage and
ncreased infarct transmurality, but only in pa-
ients with poor residual flow (TIMI flow grade 0
o 1) and no collaterals. In a multivariate analysis,
ymptom-to-balloon time, residual TIMI flow
rade 2 or more, collateral flow, and microvascu-
ar obstruction by CMR were significantly and
ndependently associated with MSI and infarct
ransmurality, whereas BARI score per se was
nly associated with MSI. Further, the impact of
ntegrade flow prior to reperfusion in limiting
nfarct size appears greater than that of collateral
ow. Unfortunately, the methods used do not
ermit rigorous quantitation of either antegrade
r collateral flow in the risk region.
These findings underscore the complex interplay
f multiple determinants of myocardial salvage in
CI for STEMI. Clearly, symptom-to-balloon
ime remains a dominant factor, but it is most
eterminative in the setting of little residual ante-
rade or collateral flow. The preponderant role of
ntegrade as opposed to collateral flow and a
eduction in endocardial surface extent of necro-
is relative to the BARI score risk region in
atients with TIMI flow grade 2 or more at
resentation are notable and clearly delineated.
verall, the results presented offer the clinician
ome additional tools in the estimation of both
he benefit of reperfusion in a given patient with
TEMI and the infarct extent. cThere are, however, some important limitations.
he number of patients with TIMI 2 to 3 antegrade
ow is small, and they have smaller infarcts and
uch less multivessel disease, so that multivariate
nalysis in a larger population would be needed to
onvincingly differentiate effects of antegrade flow
rom those of infarct size and multivessel disease. In
ddition, the number of MACE events is very
mall, and given the multiple differences between
he groups compared, caution must be observed in
rawing any conclusions from that analysis. Fur-
her, one wonders whether expression of myocardial
alvage only as percent left ventricular myocardial
olume is really the best approach. Using this
pproach, vessels with smaller risk regions will
nevitably show less salvage than vessels with larger
isk regions. But we also want to know what
roportion of the risk region itself has been salvaged
n order to better evaluate treatment success. Thus,
n additional salvage index based on the ratio of
iable myocardium at risk to total risk region size
ould also be extremely helpful.
Finally, although the methods used in the study
ave served the investigators very well, they may
ave been overtaken by recent developments in
MR. In particular, CMR imaging of myocardial
dema in both the infarct itself and the reversibly
njured, but viable, risk region surrounding it, using
2-weighted CMR sequences has now become
ufficiently reliable to provide an alternative, more
irect method than the BARI score technique for
isk region quantitation (11–15). Although evi-
ently not available at the time of initiation of data
ollection for this study, CMR edema imaging now
ppears to be the preferred method for determina-
ion of risk region size and is easily added to a CMR
tudy that includes imaging ventricular size and
unction by cine CMR and infarct size by delayed
nhancement. Indeed, the combination of T2-
eighted and delayed enhancement imaging has
lready provided a very compelling demonstration
f the impact of time to reperfusion on myocardial
alvage (15). Thus, although the present study
rovides valuable information on myocardial sal-
age, newer methods and evaluation of additional
alvage indexes appear likely to further advance our
nderstanding of this important problem in the
ear future.
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